United States · FDA National Drug Code directory

MOTPOLY XR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73289-0065_3a10a8ff-87ff-a36b-e063-6394a90a473c
Product NDC
73289-0065
Form
CAPSULE, EXTENDED RELEASE
Composition / generic term
lacosamide
Labeler
Aucta Pharmaceuticals, Inc.
Marketing category
NDA
Marketing start / end (source format)
20230505
Source listing expiry
20261231

Source-listed ingredients

  • LACOSAMIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0065-2) · 73289-0065-2

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →